BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31553703)

  • 1. Dusp6 inhibits epithelial-mesenchymal transition in endometrial adenocarcinoma via ERK signaling pathway.
    Fan MJ; Liang SM; He PJ; Zhao XB; Li MJ; Geng F
    Radiol Oncol; 2019 Sep; 53(3):307-315. PubMed ID: 31553703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor suppressor dual-specificity phosphatase 6 (DUSP6) impairs cell invasion and epithelial-mesenchymal transition (EMT)-associated phenotype.
    Wong VC; Chen H; Ko JM; Chan KW; Chan YP; Law S; Chua D; Kwong DL; Lung HL; Srivastava G; Tang JC; Tsao SW; Zabarovsky ER; Stanbridge EJ; Lung ML
    Int J Cancer; 2012 Jan; 130(1):83-95. PubMed ID: 21387288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual-specificity phosphatase 6 (Dusp6), a negative regulator of FGF2/ERK1/2 signaling, enhances 17β-estradiol-induced cell growth in endometrial adenocarcinoma cell.
    Zhang H; Guo Q; Wang C; Yan L; Fu Y; Fan M; Zhao X; Li M
    Mol Cell Endocrinol; 2013 Aug; 376(1-2):60-9. PubMed ID: 23419500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DUSP5 and DUSP6, two ERK specific phosphatases, are markers of a higher MAPK signaling activation in BRAF mutated thyroid cancers.
    Buffet C; Hecale-Perlemoine K; Bricaire L; Dumont F; Baudry C; Tissier F; Bertherat J; Cochand-Priollet B; Raffin-Sanson ML; Cormier F; Groussin L
    PLoS One; 2017; 12(9):e0184861. PubMed ID: 28910386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorene-9-bisphenol inhibits epithelial-mesenchymal transition of human endometrial cancer Ishikawa cells by repressing TGF-β signaling pathway.
    Wang L; Zhuang T; Li F; Wei W
    Environ Sci Pollut Res Int; 2019 Sep; 26(26):27407-27413. PubMed ID: 31327139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FAT1 prevents epithelial mesenchymal transition (EMT) via MAPK/ERK signaling pathway in esophageal squamous cell cancer.
    Hu X; Zhai Y; Kong P; Cui H; Yan T; Yang J; Qian Y; Ma Y; Wang F; Li H; Cheng C; Zhang L; Jia Z; Li Y; Yang B; Xu E; Wang J; Yang J; Bi Y; Chang L; Wang Y; Zhang Y; Song B; Li G; Shi R; Liu J; Zhang M; Cheng X; Cui Y
    Cancer Lett; 2017 Jul; 397():83-93. PubMed ID: 28366557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infrequent methylation of the DUSP6 phosphatase in endometrial cancer.
    Chiappinelli KB; Rimel BJ; Massad LS; Goodfellow PJ
    Gynecol Oncol; 2010 Oct; 119(1):146-50. PubMed ID: 20638106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The involvement of FBP1 in prostate cancer cell epithelial mesenchymal transition, invasion and metastasis by regulating the MAPK signaling pathway.
    Zhang YP; Liu KL; Yang Z; Lu BS; Qi JC; Han ZW; Yin YW; Zhang M; Chen DM; Wang XW; Li W; Xin H
    Cell Cycle; 2019 Oct; 18(19):2432-2446. PubMed ID: 31448674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual-specificity phosphatase 6 plays a critical role in the maintenance of a cancer stem-like cell phenotype in human endometrial cancer.
    Kato M; Onoyama I; Yoshida S; Cui L; Kawamura K; Kodama K; Hori E; Matsumura Y; Yagi H; Asanoma K; Yahata H; Itakura A; Takeda S; Kato K
    Int J Cancer; 2020 Oct; 147(7):1987-1999. PubMed ID: 32159851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of fibroblast growth factor 2 contributes to endometriosis through SPRYs/DUSP6/ERK signaling pathway.
    Yu X; Wang Y; Tan X; Li M
    Acta Histochem; 2021 Jul; 123(5):151749. PubMed ID: 34224989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD147 promotes breast cancer migration and invasion by inducing epithelial-mesenchymal transition via the MAPK/ERK signaling pathway.
    Li F; Wang J; Yan YQ; Bai CZ; Guo JQ
    BMC Cancer; 2023 Dec; 23(1):1214. PubMed ID: 38066486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual specificity phosphatase 6 (DUSP6) is an ETS-regulated negative feedback mediator of oncogenic ERK signaling in lung cancer cells.
    Zhang Z; Kobayashi S; Borczuk AC; Leidner RS; Laframboise T; Levine AD; Halmos B
    Carcinogenesis; 2010 Apr; 31(4):577-86. PubMed ID: 20097731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FGFR3 promotes the growth and malignancy of melanoma by influencing EMT and the phosphorylation of ERK, AKT, and EGFR.
    Li L; Zhang S; Li H; Chou H
    BMC Cancer; 2019 Oct; 19(1):963. PubMed ID: 31619201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of dual-specificity phosphatase 6, a negative regulator of oncogenic ERK signaling, by ACA-28 induces apoptosis in NIH/3T3 cells overexpressing HER2/ErbB2.
    Kanda Y; Mizuno A; Takasaki T; Satoh R; Hagihara K; Masuko T; Endo Y; Tanabe G; Sugiura R
    Genes Cells; 2021 Feb; 26(2):109-116. PubMed ID: 33249692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia-inducible factor 1α-induced epithelial-mesenchymal transition of endometrial epithelial cells may contribute to the development of endometriosis.
    Xiong Y; Liu Y; Xiong W; Zhang L; Liu H; Du Y; Li N
    Hum Reprod; 2016 Jun; 31(6):1327-38. PubMed ID: 27094478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-cadherin promotes thyroid tumorigenesis through modulating major signaling pathways.
    Da C; Wu K; Yue C; Bai P; Wang R; Wang G; Zhao M; Lv Y; Hou P
    Oncotarget; 2017 Jan; 8(5):8131-8142. PubMed ID: 28042956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PDGF-D/PDGFRβ promotes tongue squamous carcinoma cell (TSCC) progression via activating p38/AKT/ERK/EMT signal pathway.
    Zhang H; Sun JD; Yan LJ; Zhao XP
    Biochem Biophys Res Commun; 2016 Sep; 478(2):845-51. PubMed ID: 27507215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BKCa participates in E2 inducing endometrial adenocarcinoma by activating MEK/ERK pathway.
    Wang F; Chen Q; Huang G; Guo X; Li N; Li Y; Li B
    BMC Cancer; 2018 Nov; 18(1):1128. PubMed ID: 30445932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin inhibits 17β-estradiol-induced epithelial-to-mesenchymal transition via βKlotho-related ERK1/2 signaling and AMPKα signaling in endometrial adenocarcinoma cells.
    Liu Z; Qi S; Zhao X; Li M; Ding S; Lu J; Zhang H
    Oncotarget; 2016 Apr; 7(16):21315-31. PubMed ID: 26824324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD133 facilitates epithelial-mesenchymal transition through interaction with the ERK pathway in pancreatic cancer metastasis.
    Ding Q; Miyazaki Y; Tsukasa K; Matsubara S; Yoshimitsu M; Takao S
    Mol Cancer; 2014 Jan; 13():15. PubMed ID: 24468059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.